Antimicrobial Susceptibility Testing Market Size
|2019 - 2029
|Base Year For Estimation
|Fastest Growing Market
*Disclaimer: Major Players sorted in no particular order
Need a report that reflects how COVID-19 has impacted this market and its growth?
Antimicrobial Susceptibility Testing Market Analysis
The antimicrobial susceptibility testing market is poised to grow at a CAGR of 5.3% over the forecast period (2022-2027).
Globally, COVID-19 has a significant and unprecedented impact on the supply of healthcare and public health across several nations. As per the article published in 2021 under the title 'Antimicrobial susceptibility patterns of respiratory Gram-negative bacterial isolates from COVID-19 patients in Switzerland', the development of bacterial superinfections in ventilated COVID-19 patients impacted by high levels of antimicrobial resistance, which in some situations necessitate continued modification of antibiotic therapy. Furthermore, the article published in 2021 under the heading 'Impact of the COVID-19 pandemic on the surveillance, prevention, and control of antimicrobial resistance: a global survey' stated that health systems have been significantly impacted by the COVID-19 pandemic. COVID-19's impacts on antimicrobial resistance surveillance, prevention, and control were investigated by the World Health Organization (WHO) Antimicrobial Resistance (AMR) Surveillance and Quality Assessment Collaborating Centers Network. Hence due to the aforementioned factors, COVID-19 had a significant impact on the market studied.
The major factors attributing to the growth of the market are the increasing prevalence of multidrug-resistant organisms and growing awareness of precision medicine. According to the Centers for Disease Control and Prevention (CDC), more than 2.8 million antibiotic-resistant infections happen in the United States every year. The increasing number of multidrug-resistant diseases increases the need for antimicrobial susceptibility testing. The rising awareness programs and initiatives for personalized medicine have a positive effect on the growth of the market and the other factor which is playing a pivotal role in taking the antimicrobial susceptibility testing market to the next level is increasing the use of the tests by the pharmaceutical companies. For instance, WHO celebrates World Antimicrobial Awareness Week (WAAW) from 18-24 November every year. The 2021 theme was Spread Awareness, Stop Resistance, which called on One Health stakeholders, policymakers, health care providers, and the public to be Antimicrobial Resistance (AMR) Awareness champions.
Hence as per the information mentioned above, the antimicrobial susceptibility testing market is expected to witness growth over the forecast period. However, stringent regulatory government policies and the challenges associated with antimicrobial susceptibility testing are expected to restrain the growth of the market over the forecast period.
Antimicrobial Susceptibility Testing Market Trends
This section covers the major market trends shaping the Antimicrobial Susceptibility Testing Market according to our research experts:
Antibacterial segments dominates the global Antimicrobial Susceptibility Testing Market
Antibacterial susceptibility testing is used to ascertain the specific drugs which affect the bacteria. These tests can guide the physician in drug preference and dosage for difficult-to-treat infections.
According to the Centers for Disease Control and Prevention 2020 report, isoniazid resistance at initial diagnosis was reported for 456 cases in the United States, including 4.8% of cases among U.S.-born persons and 9.5% of cases among non-U.S.-born persons in 2020. Furthermore, government initiatives and product awareness programs boost market growth. For instance, the 2021 Canadian Antimicrobial Resistance Surveillance System (CARSS) report presents an integrated view of available national-level data on antimicrobial resistance (AMR) and antimicrobial use (AMU) generated by the Public Health Agency of Canada (PHAC) and its partners from human populations and animal populations.
Thus, considering the above-mentioned facts, the antibacterial segment is anticipated to face a growth over the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall antimicrobial susceptibility testing market, throughout the forecast period. This is due to factors such as the rising incidence of antibiotic-resistant infections and increased use of antibiotics in the studies region. For instance, as per 'COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022', azithromycin use was 150% higher in April 2020 and 82% higher in December 2020 in Nursing Homes. Azithromycin prescribing remained elevated through October 2020.
Government funding and initiatives for the awareness and support for antimicrobial resistance boost the market growth. For instance, according to the Antibiotic Resistance Threats United States report, in 2020 funding through CDC's AR Solutions Initiative supports all 50 state health departments, several local health departments, and Puerto Rico, Guam, and the U.S. Virgin Islands. CDC also collaborates with other federal agencies, state and local health departments, patients, public health partners, and the private sector to address this threat. CDC invested in more than 330 innovative antimicrobial resistance projects in more than 30 countries to slow the spread of resistance globally till 2020. Through these investments and partnerships, CDC is transforming how the nation and world combat and slow antimicrobial resistance at all levels. With these investments, CDC implemented the AR Solutions Initiative to work toward meeting the national goals. This appropriation has increased to more than USD 200 million as of the fiscal year 2021. Furthermore, The WHO HIV drug resistance (HIVDR) report 2021 shows substantial progress in the implementation of HIVDR surveillance. Among adults failing non-nucleoside reverse transcriptase inhibitor(NNRTI) first-line antiretroviral therapy(ART), the levels of resistance to these drugs ranged from 50% to 97%. The high levels of HIVDR among individuals with treatment failure, emphasize the need to scale up viral load testing and enhanced adherence counseling and promptly switch individuals with treatment failure.
Furthermore, well-established awareness programs for precision medicine and the use of antimicrobial testing, beneficial government initiatives, and an increase in the number of research partnerships are some of the drivers expected to increase the market growth. For instance, in 2020 the White House released the second United States National Action Plan for Combating Antibiotic-Resistant Bacteria for 2020-2025 with coordinated, strategic actions to improve the health and well-being of all Americans.
As per the factors mentioned above, North America is expected to face growth over the forecast period.
Antimicrobial Susceptibility Testing Industry Overview
The antimicrobial susceptibility testing mṇarket is moderately competitive and consists of several major players. The market players are focusing on advancing the technologies, new product launches to expand their market share. The key market players operating in the antimicrobial susceptibility testing market include biomerieux, Bio-Rad Laboratories, Inc, HiMedia Laboratories, Alifax, and Becton Dickinson among others.
Antimicrobial Susceptibility Testing Market Leaders
Bio-Rad Laboratories, Inc
Becton Dickinson, and Company
*Disclaimer: Major Players sorted in no particular order
Antimicrobial Susceptibility Testing Market News
- In May 2022, Qualigen Therapeutics announced that NanoSynex Ltd, a company with whom Qualigen recently entered into definitive agreements to acquire a majority stake, featured at BioMed Israel. Innovative Technology by NanoSynex focuses to accelerate antimicrobial susceptibility test results times by six-fold.
- In April 2022, COPAN Diagnostics demonstrated its range of fully automated solutions for identification and antimicrobial susceptibility testing (AST) in clinical microbiology at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022). COPAN demonstrated the Food and Drug Administration-cleared Colibri, a fully automated specimen workup instrument designed to prepare MALDI-TOF ID targets and create bacterial suspensions for AST.
Antimicrobial Susceptibility Testing Market Report - Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Multi Drug Resistance Organisms
4.2.2 Rising Use of Antimicrobial Susceptibility Testing by Pharmaceutical Companies
4.2.3 Growing Awareness of Precision Medicine
4.3 Market Restraints
4.3.1 Stringent Government Regulatory Policies
4.3.2 Challenges associated with Antimicrobial Susceptibility Testing
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD Million)
5.1 By Product
5.1.1 Manual Antimicrobial Susceptibility Testing
220.127.116.11 MIC strips
18.104.22.168 Susceptibility Plates
5.1.2 Automated Antimicrobial Susceptibility Testing Products
5.2 By Type
5.2.1 Antibacterial Testing
5.2.2 Antifungal Testing
5.2.3 Antiparasitic Testing
5.3 By Application
5.3.2 Drug Discovery and Development
5.4.1 North America
22.214.171.124 United States
126.96.36.199 United Kingdom
188.8.131.52 Rest of Europe
5.4.3 Asia Pacific
184.108.40.206 South Korea
220.127.116.11 Rest of Asia-Pacific
5.4.4 Middle East and Africa
18.104.22.168 South Africa
22.214.171.124 Rest of Middle East and Africa
5.4.5 South America
126.96.36.199 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 bioMérieux SA
6.1.2 Bio-Rad Laboratories, Inc
6.1.3 HiMedia Laboratories
6.1.5 Becton Dickinson, and Company
6.1.6 Creative Diagnostics
6.1.7 Resistell AG
6.1.8 Danaher Corporation
6.1.9 Thermo Fisher Scientific Inc
6.1.10 Merck KGaA
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Antimicrobial Susceptibility Testing Market Research FAQs
What is the current Global Antimicrobial Susceptibility Testing Market size?
The Global Antimicrobial Susceptibility Testing Market is projected to register a CAGR of 5.30% during the forecast period (2024-2029)
Who are the key players in Global Antimicrobial Susceptibility Testing Market?
Bio-Rad Laboratories, Inc, HiMedia Laboratories, Alifax, bioMérieux SA and Becton Dickinson, and Company are the major companies operating in the Global Antimicrobial Susceptibility Testing Market.
Which is the fastest growing region in Global Antimicrobial Susceptibility Testing Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Antimicrobial Susceptibility Testing Market?
In 2024, the North America accounts for the largest market share in Global Antimicrobial Susceptibility Testing Market.
What years does this Global Antimicrobial Susceptibility Testing Market cover?
The report covers the Global Antimicrobial Susceptibility Testing Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Antimicrobial Susceptibility Testing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Antimicrobial Susceptibility Testing Industry Report
Statistics for the 2024 Antimicrobial Susceptibility Testing market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Antimicrobial Susceptibility Testing analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.